GET IN TOUCH
Have questions?
Contact our client services team today.
- services@mplnet.com
- 865.380.9746
- 250 E. Broadway Maryville, TN 37804
Women’s Health
Women's Health
MPLN has been providing molecular diagnostic testing for HPV, chlamydia (CT), and gonorrhea (NG) for over thirty years. Due to its extensive participation in clinical trials related to sexually transmitted infections (STIs), the laboratory has access to the latest technological advances and automation. We share these advancements with our clients to enhance their services.
Liquid Cytology Testing
Test from a single liquid cytology specimen
(ThinPrep® PAP solution or SurePath™ Test Pack) for:
- Chlamydia trachomatis (CT)
- Neisseria gonorrhoeae (NG)
- Human papillomavirus (HPV) and HPV genotyping (HPV G)
- Trichomonas vaginalis (TV)
- Herpes simplex virus (HSV)
Visit the CDC’s site for more information on the prevalence of STDs: www.cdc.gov/std
Aptima Trichomonas Vaginalis Assay
- First FDA-cleared amplified nucleic acid test available to detect Trichomonas vaginalis
- Requires a fraction of one organism for detection vs. the 10,000 organisms required for wet mount microscopy
- Detects up to 100% of all Trichomonas infections
- Available for use in both symptomatic and
asymptomatic women
APTIMA® Combo 2/HPV/Trichomonas
Higher sensitivity, greater specificity:
- FDA-cleared to detect Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NC)
- Second generation test eliminates inhibition and cross-reactivity problems and minimizes equivocal results.
- Three technologies: target capture, transcription-mediated amplification, and dual kinetic assay
Aptima HPV Assay
Provides enhanced testing, refined results, and offers
the following benefits:
- FDA approved to detect 14 high-risk types of human papillomavirus (HPV)
- Based on a clinical evaluation of more than 10,000 U.S. women with normal cytology results, the APTIMA® HPV Assay demonstrated superior clinical specificity and sensitivity with 24% fewer false positives compared to competitor FDA approved DNA tests
- Fewer false positives translates to fewer unnecessary colposcopies.
Hologic Gen-Probe APTIMA® HPV 16 18/45 Genotype Assay
- Identifies the two most highly oncogenic and persistent high-risk HPV types known to cause high-grade cervical neoplasia
- Facilitates risk-stratification of patients at greater risk for cervical disease in order to tailor care more appropriately
